» Articles » PMID: 11463014

The Influence of Hospital Volume on Survival After Resection for Lung Cancer

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2001 Jul 21
PMID 11463014
Citations 189
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Among patients who have undergone high-risk operations for cancer, postoperative mortality rates are often lower at hospitals where more of these procedures are performed. We undertook a population-based study to estimate the extent to which the number of procedures performed at a hospital (hospital volume) is associated with survival after resection for lung cancer.

Methods: We studied patients 65 years old or older who received a diagnosis of stage I, II, or IIIA non-small-cell lung cancer between 1985 and 1996, resided in 1 of the 10 study areas covered by the Surveillance, Epidemiology, and End Results Program, and underwent surgery at a hospital that participates in the Nationwide Inpatient Sample (2118 patients and 76 hospitals).

Results: The volume of procedures at the hospital was positively associated with the survival of patients (P<0.001). Five years after surgery, 44 percent of patients who underwent operations at the hospitals with the highest volume were alive, as compared with 33 percent of those who underwent operations at the hospitals with the lowest volume. Patients at the highest-volume hospitals also had lower rates of postoperative complications (20 percent vs. 44 percent) and lower 30-day mortality (3 percent vs. 6 percent) than those at the lowest-volume hospitals.

Conclusions: Patients who undergo resection for lung cancer at hospitals that perform large numbers of such procedures are likely to survive longer than patients who have such surgery at hospitals with a low volume of lung-resection procedures.

Citing Articles

Inpatient lung cancer surgery outcomes in Illinois.

Ahmed A, Logan C, Odell D, Feinglass J Surg Pract Sci. 2025; 14():100206.

PMID: 39845851 PMC: 11750004. DOI: 10.1016/j.sipas.2023.100206.


A scoping review of lung cancer surgery with curative intent: workup, fitness assessment, clinical outcomes.

Hardavella G, Carlea F, Karampinis I, Patirelis A, Athanasiadi K, Lioumpas D Breathe (Sheff). 2024; 20(2):240046.

PMID: 39193455 PMC: 11348919. DOI: 10.1183/20734735.0046-2024.


Minimally invasive versus open esophagectomy for resectable thoracic esophageal cancer (NST 1502): a multicenter prospective cohort study.

Mao Y, Gao S, Li Y, Chen C, Hao A, Wang Q J Natl Cancer Cent. 2024; 3(2):106-114.

PMID: 39035730 PMC: 11256603. DOI: 10.1016/j.jncc.2023.02.002.


Impact of Center Volume on Cardiopulmonary and Mortality Outcomes after Immune-Checkpoint Inhibitors for Cancer: A Systematic Review and Meta-Analysis.

Rahouma M, Mynard N, Baudo M, Khairallah S, Al-Thani S, Dabsha A Cancers (Basel). 2024; 16(6).

PMID: 38539471 PMC: 10969050. DOI: 10.3390/cancers16061136.


Comprehensive value implications of surgeon volume for lung cancer surgery: Use of an analytic framework within a regional health system.

Maxwell C, Bhat A, Falls S, Bigbee M, Yin Y, Chalikonda S JTCVS Open. 2024; 17:286-294.

PMID: 38420536 PMC: 10897681. DOI: 10.1016/j.xjon.2023.11.010.